Works matching AU Sanacora, Gerard


Results: 51
    1
    2
    3
    4

    Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions.

    Published in:
    World Psychiatry, 2023, v. 22, n. 3, p. 394, doi. 10.1002/wps.21120
    By:
    • McIntyre, Roger S.;
    • Alsuwaidan, Mohammad;
    • Baune, Bernhard T.;
    • Berk, Michael;
    • Demyttenaere, Koen;
    • Goldberg, Joseph F.;
    • Gorwood, Philip;
    • Ho, Roger;
    • Kasper, Siegfried;
    • Kennedy, Sidney H.;
    • Ly‐Uson, Josefina;
    • Mansur, Rodrigo B.;
    • McAllister‐Williams, R. Hamish;
    • Murrough, James W.;
    • Nemeroff, Charles B.;
    • Nierenberg, Andrew A.;
    • Rosenblat, Joshua D.;
    • Sanacora, Gerard;
    • Schatzberg, Alan F.;
    • Shelton, Richard
    Publication type:
    Article
    5

    Candidate biomarkers in psychiatric disorders: state of the field.

    Published in:
    World Psychiatry, 2023, v. 22, n. 2, p. 236, doi. 10.1002/wps.21078
    By:
    • Abi‐Dargham, Anissa;
    • Moeller, Scott J.;
    • Ali, Farzana;
    • DeLorenzo, Christine;
    • Domschke, Katharina;
    • Horga, Guillermo;
    • Jutla, Amandeep;
    • Kotov, Roman;
    • Paulus, Martin P.;
    • Rubio, Jose M.;
    • Sanacora, Gerard;
    • Veenstra‐VanderWeele, Jeremy;
    • Krystal, John H.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    13
    14

    Ketamine for the Treatment of Depression.

    Published in:
    2017
    By:
    • Kraus, Christoph;
    • Lanzenberger, Rupert;
    • Kasper, Siegfried;
    • Rasmussen, Keith G.;
    • Golzari, Samad E. J.;
    • Mahmoodpoor, Ata;
    • Sanacora, Gerard
    Publication type:
    journal article
    15
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine.

    Published in:
    International Journal of Neuropsychopharmacology, 2022, v. 25, n. 10, p. 827, doi. 10.1093/ijnp/pyac055
    By:
    • Bloomfield-Clagett, Bartholt;
    • Ballard, Elizabeth D;
    • Greenstein, Deanna K;
    • Wilkinson, Samuel T;
    • Grunebaum, Michael F;
    • Murrough, James W;
    • Mathew, Sanjay J;
    • Phillips, Jennifer L;
    • Fava, Maurizio;
    • Sanacora, Gerard;
    • Zarate, Carlos A
    Publication type:
    Article
    30
    31
    32
    33

    Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 6, p. e2417786, doi. 10.1001/jamanetworkopen.2024.17786
    By:
    • Jha, Manish Kumar;
    • Wilkinson, Samuel T.;
    • Krishnan, Kamini;
    • Collins, Katherine A.;
    • Sanacora, Gerard;
    • Murrough, James;
    • Goes, Fernando;
    • Altinay, Murat;
    • Aloysi, Amy;
    • Asghar-Ali, Ali;
    • Barnett, Brian;
    • Chang, Lee;
    • Costi, Sara;
    • Malone, Donald;
    • Nikayin, Sina;
    • Nissen, Steven E.;
    • Ostroff, Robert;
    • Reti, Irving;
    • Wolski, Kathy;
    • Wang, Dong
    Publication type:
    Article
    34
    35
    36
    37

    Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2023, v. 330, n. 9, p. 843, doi. 10.1001/jama.2023.14530
    By:
    • Raison, Charles L.;
    • Sanacora, Gerard;
    • Woolley, Joshua;
    • Heinzerling, Keith;
    • Dunlop, Boadie W.;
    • Brown, Randall T.;
    • Kakar, Rishi;
    • Hassman, Michael;
    • Trivedi, Rupal P.;
    • Robison, Reid;
    • Gukasyan, Natalie;
    • Nayak, Sandeep M.;
    • Hu, Xiaojue;
    • O'Donnell, Kelley C.;
    • Kelmendi, Benjamin;
    • Sloshower, Jordan;
    • Penn, Andrew D.;
    • Bradley, Ellen;
    • Kelly, Daniel F.;
    • Mletzko, Tanja
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Intravenous arketamine for treatment-resistant depression: open-label pilot study.

    Published in:
    European Archives of Psychiatry & Clinical Neuroscience, 2021, v. 271, n. 3, p. 577, doi. 10.1007/s00406-020-01110-5
    By:
    • Leal, Gustavo C.;
    • Bandeira, Igor D.;
    • Correia-Melo, Fernanda S.;
    • Telles, Manuela;
    • Mello, Rodrigo P.;
    • Vieira, Flavia;
    • Lima, Cassio S.;
    • Jesus-Nunes, Ana Paula;
    • Guerreiro-Costa, Lívia N. F.;
    • Marback, Roberta F.;
    • Caliman-Fontes, Ana Teresa;
    • Marques, Breno L. S.;
    • Bezerra, Marília L. O.;
    • Dias-Neto, Alberto L.;
    • Silva, Samantha S.;
    • Sampaio, Aline S.;
    • Sanacora, Gerard;
    • Turecki, Gustavo;
    • Loo, Colleen;
    • Lacerda, Acioly L. T.
    Publication type:
    Article
    48
    49

    Lower synaptic density is associated with depression severity and network alterations.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09562-7
    By:
    • Holmes, Sophie E.;
    • Scheinost, Dustin;
    • Finnema, Sjoerd J.;
    • Naganawa, Mika;
    • Davis, Margaret T.;
    • DellaGioia, Nicole;
    • Nabulsi, Nabeel;
    • Matuskey, David;
    • Angarita, Gustavo A.;
    • Pietrzak, Robert H.;
    • Duman, Ronald S.;
    • Sanacora, Gerard;
    • Krystal, John H.;
    • Carson, Richard E.;
    • Esterlis, Irina
    Publication type:
    Article
    50